These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 35265754)

  • 21. Mitochondrial Dysfunction in Individuals with Diabetic Kidney Disease: A Systematic Review.
    Flemming N; Pernoud L; Forbes J; Gallo L
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury.
    Su J; Ye D; Gao C; Huang Q; Gui D
    Mol Biol Rep; 2020 Oct; 47(10):8023-8035. PubMed ID: 32918716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New progress in drugs treatment of diabetic kidney disease.
    Wang J; Xiang H; Lu Y; Wu T; Ji G
    Biomed Pharmacother; 2021 Sep; 141():111918. PubMed ID: 34328095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
    Tuttle KR; Brosius FC; Cavender MA; Fioretto P; Fowler KJ; Heerspink HJL; Manley T; McGuire DK; Molitch ME; Mottl AK; Perreault L; Rosas SE; Rossing P; Sola L; Vallon V; Wanner C; Perkovic V
    Am J Kidney Dis; 2021 Jan; 77(1):94-109. PubMed ID: 33121838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DsbA-L deficiency exacerbates mitochondrial dysfunction of tubular cells in diabetic kidney disease.
    Gao P; Yang M; Chen X; Xiong S; Liu J; Sun L
    Clin Sci (Lond); 2020 Apr; 134(7):677-694. PubMed ID: 32167139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.
    Qi H; Casalena G; Shi S; Yu L; Ebefors K; Sun Y; Zhang W; D'Agati V; Schlondorff D; Haraldsson B; Böttinger E; Daehn I
    Diabetes; 2017 Mar; 66(3):763-778. PubMed ID: 27899487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of Mitochondrial Dysfunction in Diabetic Kidney Disease: New Perspectives from Mechanism to Therapy.
    Yang Y; Liu J; Shi Q; Guo B; Jia H; Yang Y; Fu S
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Glucose Metabolism and Mitochondrial Function in Diabetic Kidney Disease.
    Stanton RC
    Curr Diab Rep; 2021 Jan; 21(2):6. PubMed ID: 33449215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Loss of Mitochondrial Quality Control in Diabetic Kidney Disease.
    Dai W; Lu H; Chen Y; Yang D; Sun L; He L
    Front Cell Dev Biol; 2021; 9():706832. PubMed ID: 34422828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial DNA: A New Predictor of Diabetic Kidney Disease.
    Huang Y; Chi J; Wei F; Zhou Y; Cao Y; Wang Y
    Int J Endocrinol; 2020; 2020():3650937. PubMed ID: 32733553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic Changes and Oxidative Stress in Diabetic Kidney Disease.
    Sakashita M; Tanaka T; Inagi R
    Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway.
    Liu X; Xu C; Xu L; Li X; Sun H; Xue M; Li T; Yu X; Sun B; Chen L
    Metabolism; 2020 Oct; 111():154334. PubMed ID: 32777444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Glimpse of Inflammation and Anti-Inflammation Therapy in Diabetic Kidney Disease.
    Liu C; Yang M; Li L; Luo S; Yang J; Li C; Liu H; Sun L
    Front Physiol; 2022; 13():909569. PubMed ID: 35874522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium-Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease.
    Alicic RZ; Neumiller JJ; Johnson EJ; Dieter B; Tuttle KR
    Diabetes; 2019 Feb; 68(2):248-257. PubMed ID: 30665953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes.
    Wheeler DC; James J; Patel D; Viljoen A; Ali A; Evans M; Fernando K; Hicks D; Milne N; Newland-Jones P; Wilding J;
    Diabetes Ther; 2020 Dec; 11(12):2757-2774. PubMed ID: 32996085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium-glucose cotransporter-2 inhibitors and non-steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin-angiotensin system blockade.
    Shenoy SV; Nagaraju SP; Bhojaraja MV; Prabhu RA; Rangaswamy D; Rao IR
    Nephrology (Carlton); 2021 Nov; 26(11):858-871. PubMed ID: 34176194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease.
    Patel DM; Bose M; Cooper ME
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KCa3.1 in diabetic kidney disease.
    Huang C; Chen XM; Pollock CA
    Curr Opin Nephrol Hypertens; 2022 Jan; 31(1):129-134. PubMed ID: 34710887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease.
    Ma L; Zhang L; Li J; Zhang X; Xie Y; Li X; Yang B; Yang H
    Mol Med; 2023 Oct; 29(1):148. PubMed ID: 37907885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.